Allergy

Gabryszewski said new data confirm early introduction guidelines are working, showing real-world declines in peanut allergy.

New data show peanut allergy rates have dropped sharply since early introduction guidelines, reducing 27% and 43% after the 2015 and 2017 guidelines, respectively.

Study finds non-celiac gluten or wheat sensitivity is more common in women and linked to IBS, anxiety, and depression.

A study found that combining the eosinophil-to-lymphocyte ratio with CT-based sinus scores predicts smell recovery after CRSwNP surgery.

A real-world study found that using baked goods with sesame paste was safer than raw sesame seeds for oral immunotherapy.

Investigators estimate that replacing individually prescribed school-based devices with spare adrenaline autoinjectors could improve access for students.

Adults given an initial 0.5 mg intramuscular epinephrine dose were less likely to need further intervention than those receiving 0.3 mg, a study found.

In a recent study, a 30 mg maintenance dose significantly increased reaction thresholds and improved immune markers in children with peanut allergy.

A new study finds that rates of peanut and other IgE-mediated food allergies declined following the 2015 and 2017 early peanut introduction guidelines.

The study showed that infants consuming blueberries had lower IL-13, higher IL-10, and improved allergy symptom trajectories compared with placebo.

Most clinicians are not considering poor home air exposure when treating persistent asthma or airway disease, Raju explains. That may be making a difference in outcomes.

A new study found that adjunct omalizumab helped most patients safely continue honeybee venom immunotherapy after prior severe allergic reactions.

A 5-year follow-up showed 76% of delabeled children reused the previously avoided antibiotic without significant adverse reactions.

A phase 1b/2a study showed CM326 significantly improved nasal polyp scores; baseline plasma TSLP levels ≥ 330 fg/mL may predict treatment response.

Oticara’s intranasal steroid cream meets primary endpoints in phase 2 trial, providing rapid, durable symptom relief for post-surgical chronic rhinosinusitis.

A 9-year real-world study found allergen immunotherapy reduced medication use and asthma flare-ups, showing lasting control of allergic rhinitis.

New research links early baby formula feeding to increased risks of peanut and multiple food allergies, highlighting the importance of colostrum.

Patients with allergic rhinitis report less satisfaction with oral antihistamines than intranasal corticosteroids or combination therapies.

A recent study reveals that small intestinal dilation significantly contributes to abdominal symptoms in adults with Food-Protein-Induced Enterocolitis Syndrome (FPIES).

A new trial reveals that educational interventions significantly enhance pediatricians' adherence to guidelines for early peanut introduction.

Subcutaneous Dpg-pol-cat significantly improved the quality of life and reduced medication use in adults with moderate to severe cat allergy.

Donidalorsen demonstrates strong efficacy in patients switching from other HAE prophylactic treatments. Lumry discusses pivotal data after FDA approval.

Lumry discuses donidalorsen, the first FDA-approved, RNA-targeted therapy for hereditary angioedema.

An audio recap of the top 5 stories in healthcare news from the week of 9/28-10/04.

Explore the latest advancements in allergy and immunology, including new therapies, FDA approvals, and innovative clinical strategies for improved patient care from Q3.